These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4016711)

  • 1. A totally implanted venous access system for the delivery of chemotherapy.
    Khoury MD; Lloyd LR; Burrows J; Berg R; Yap J
    Cancer; 1985 Sep; 56(5):1231-4. PubMed ID: 4016711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular access for intravenous chemotherapy: totally implanted systems.
    Meurette J; Depadt G; Meynadier J
    Eur J Surg Oncol; 1985 Sep; 11(3):295-8. PubMed ID: 4029413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified insertion of the Port-A-Cath implantable drug-delivery system.
    Del Campo C
    Can J Surg; 1985 Sep; 28(5):435-6. PubMed ID: 4027791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous access ports: frequency and management of complications in oncology patients.
    Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
    Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implantable chambers for intravenous cytotoxic chemotherapy. Experience of 9 anticancer centers].
    Bobin JY
    Presse Med; 1986 May; 15(20):911-4. PubMed ID: 2940570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implanted venous access system in oncology. Review of 296 cases].
    Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
    Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy.
    Brincker H; Saeter G
    Cancer; 1986 Mar; 57(6):1124-9. PubMed ID: 3943036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Totally implanted venous and arterial access system to replace external catheters in cancer treatment.
    Niederhuber JE; Ensminger W; Gyves JW; Liepman M; Doan K; Cozzi E
    Surgery; 1982 Oct; 92(4):706-12. PubMed ID: 7123491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
    Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New options for central venous access in cancer chemotherapy. Multiple lumen catheters.
    Kaufman JL; Nissenblatt MJ
    Am Surg; 1986 Feb; 52(2):105-7. PubMed ID: 3946932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors.
    Carde P; Cosset-Delaigue MF; Laplanche A; Chareau I
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):939-44. PubMed ID: 2666137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central venous access in pediatric patients. A 6-year experience].
    Torramade Ribas J; Hernández Lizoáin JL; Benito Fernández C; González Fernández J; Balen Rivera E; Martínez Regueira F; Pardo Sánchez F; Cienfuegos Suárez JA
    An Esp Pediatr; 1993 Mar; 38(3):251-4. PubMed ID: 8460845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute.
    Mori Y; Nagayama S; Kawamura J; Hasegawa S; Tanaka E; Okabe H; Takeuchi M; Sonobe M; Matsumoto S; Kanai M; Muto M; Chiba T; Sakai Y
    Int J Clin Oncol; 2016 Jun; 21(3):474-82. PubMed ID: 26507141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Totally implantable catheters. Experience at the University Hospital Center Vaudois from March 1984 to December 1987].
    Amrein E; Leyvraz S; Genton A; Pettavel J; Beck D
    Helv Chir Acta; 1989 Jun; 56(1-2):289-93. PubMed ID: 2777615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.
    Bow EJ; Kilpatrick MG; Clinch JJ
    J Clin Oncol; 1999 Apr; 17(4):1267. PubMed ID: 10561188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Totally implantable central venous access devices in patients with cancer. Experience at a private oncology center].
    Cortés-Flores AO; Morgan-Villela G; Juárez-Uzeta EA; Fuentes-Orozco C; Jiménez-Tornero J; González-Ojeda A
    Cir Cir; 2012; 80(5):429-34. PubMed ID: 23351446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.